Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 4:37 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1945–1968 of 3,979 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Erectile Dysfunction
Interventions: Placebo, Tadalafil; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 372 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Chronic Kidney Diseases, Bladder Dysfunction, Bladder Absence, Posterior Urethral Valve, Neurogenic Bladder, Bladder Exstrophy, Bladder Outlet Obstruction, Failure, Kidney, Transplant
Interventions: Concomitant Renal and Urinary Bladder Allograft Transplantation; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 1 Year to 60 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 2
States / cities: Rochester, Minnesota

Conditions: Prediabetes, Healthy (Controls)
Interventions: Ketone Monoester (KE), Placebo; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 60 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Birmingham, Alabama

Conditions: Alzheimer Disease
Interventions: 18F-AV-1451; Drug
Lead sponsor: Tammie L. S. Benzinger, MD, PhD; Other
Eligibility: 65 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Respiratory Distress Syndrome, Adult, Bronchiolitis Obliterans, Pneumonia
Interventions: etanercept; Drug
Lead sponsor: FDA Office of Orphan Products Development; Federal
Eligibility: 12 Months and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Chronic Fatigue Syndrome
Interventions: Not listed
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Cognitive Decline, Cognitive Impairment
Interventions: TMS; Device
Lead sponsor: San Francisco Neurology and Sleep Center; Other
Eligibility: 50 Years to 90 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Mild Cognitive Impairment, Alzheimer's Disease
Interventions: Mail and Live Phone, Interactive Voice Response (IVR), Home-based Computer Kiosk, Traditional Evaluation Instruments; Behavioral
Lead sponsor: Alzheimer's Disease Cooperative Study (ADCS); Other
Eligibility: 75 Years and older
Enrollment: 640 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 28
States / cities: Birmingham, Alabama • Sun City, Arizona • Irvine, California + 23 more

Conditions: Male Erectile Disorder, Prostate Cancer, Radiation Toxicity
Interventions: Placebo, Oral L-Arginine; Other · Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Male only
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH)
Interventions: Miricorilant (Cohort A), Placebo (Cohort A), Miricorilant (Cohort B), Placebo (Cohort B); Drug
Lead sponsor: Corcept Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 48
States / cities: Chandler, Arizona • Tucson, Arizona • Huntington Park, California + 41 more

Conditions: RV Dysfunction
Interventions: No intervention; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Aging, Vascular Stiffness, Endothelial Dysfunction
Interventions: Endocalyx Pro (Microvascular Health Solutions, US Patent Number: 9943572); Dietary Supplement
Lead sponsor: University of Iowa; Other
Eligibility: 60 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Urologic Injuries
Interventions: Bowel function post Holmium Laser Enucleation of the Prostate; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 89 Years · Male only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypertension, Pulmonary Artery, Ventricular Dysfunction, Left
Interventions: sildenafil; Drug
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 80 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Acute Lymphoblastic Leukemia
Interventions: Active tDCS, Sham tDCS; Device
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 18 Years to 39 Years
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Congestive Heart Failure, Atrial Fibrillation, Arrhythmia
Interventions: Pulmonary Vein Isolation (PVI); Procedure
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Ridgewood, New Jersey • New York, New York

Conditions: Female Sexual Dysfunction
Interventions: percutaneous tibial nerve stimulation (PTNS), Sham procedure; Device
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Voiding Dysfunction
Interventions: Control Group, Test Group; Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Hematopoietic Cell Transplantation
Interventions: Biorepository Trial; Other
Lead sponsor: Duke University; Other
Eligibility: 0 Years to 26 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 3
States / cities: Rochester, Minnesota • Durham, North Carolina • Houston, Texas

Conditions: Emotions, Endothelial Dysfunction
Interventions: Anger Induction, Depressed Mood Induction, Anxiety Induction, Neutral emotion task; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: oxaliplatin; Drug
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2000
U.S. locations: 11
States / cities: Los Angeles, California • Sacramento, California • Washington D.C., District of Columbia + 6 more

Conditions: Hypogonadism, Male, Cancer, Fatigue
Interventions: testosterone 1.62% gel, placebo gel; Drug · Other
Lead sponsor: Seattle Institute for Biomedical and Clinical Research; Other
Eligibility: 55 Years and older · Male only
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 3
States / cities: Augusta, Georgia • Boston, Massachusetts • Seattle, Washington

Conditions: Eustachian Tube Dysfunction, Chronic Otitis Media
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Cancer, Cognitive Impairment
Interventions: Behavioral: COPE +; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

A Study in Erectile Dysfunction

Concomitant Renal and Urinary Bladder Allograft Transplantation

Effects of Exogenous Ketones on Cognitive Function in Older Adults With Prediabetes?

Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans

Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation

ME/CFS: Activity Patterns and Autonomic Dysfunction

Effects of Accelerated rTMS on Cognitive Function

Home-Based Assessment for Alzheimer Disease Prevention

L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors

A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

Paceport Swan-Ganz Data Collection Study

Restoring Glycocalyx Thickness in Older Adults to Improve Vascular Function

Bowel Dysfunction and HoLEP Outcomes

Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.

Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)

Catheter Ablation for Atrial Fibrillation and Heart Failure

Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction

Evaluating the Optimal Volume Voided for Passage of a Backfill-Assisted Voiding Trial Following Urogynecologic Surgery

A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).

Study of the Effects of Negative Emotions on Endothelial Function

Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

Risk Factors and Potential Causes of Eustachian Tube Dysfunction in Adults

Cancer and Mild Cognitive Impairment Dyadic Intervention